Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Weed (BUDZ) Capital Expenditures (2017 - 2023)

Weed has reported Capital Expenditures over the past 9 years, most recently at $10000.0 for Q1 2023.

  • Quarterly results put Capital Expenditures at $10000.0 for Q1 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $10000.0 (changed N/A YoY), and the annual figure for FY2023 was $10000.0, changed.
  • Capital Expenditures for Q1 2023 was $10000.0 at Weed, up from -$3734.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for BUDZ hit a ceiling of $163590.0 in Q4 2020 and a floor of -$163590.0 in Q3 2020.
  • Median Capital Expenditures over the past 5 years was $3356.5 (2019), compared with a mean of $2163.2.
  • Peak annual rise in Capital Expenditures hit 99.13% in 2019, while the deepest fall reached 99.13% in 2019.
  • Weed's Capital Expenditures stood at $2979.0 in 2019, then surged by 5391.44% to $163590.0 in 2020, then crashed by 97.72% to $3734.0 in 2021, then tumbled by 200.0% to -$3734.0 in 2022, then skyrocketed by 367.81% to $10000.0 in 2023.
  • The last three reported values for Capital Expenditures were $10000.0 (Q1 2023), -$3734.0 (Q4 2022), and $3734.0 (Q1 2021) per Business Quant data.